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Background
Cancer cell transformation entails significant alterations
in intracellular metabolic pathways one of which is the
aerobic glycolysis phenotype [1]. The original formalism of
this phenotype was hypothesized by Otto Warburg in
1950s and main tenet of his hypothesis was that mito-
chondrial dysfunction in cancer cells leads to aerobic
glycolysis phenotype [2]. It is not clear in the field if
mitochondrial dysfunction is a necessary condition for
observing the aerobic glycolysis phenotype and further it
is also not known if this “metabolic switch” phenotype
is reversible. We recently showed that mitochondrial
dysfunction (generated by gene silencing of catalytic
subunit of mitochondrial complex I in transformed cells
indeed can induce metabolic switch phenotype [3].
We further demonstrated that this can be reversed for
moderate mitochondrial dysfunction models. In the
present study, we ask if we can achieve tumor control in
preclinical animal models by systematic modulation of
mitochondrial complex I function via metabolic adaption
to clinically relevant pharmacological modulators of
mitochondria in breast cancer cells.
Materials and methods
We used two human breast cancer cell lines (MDA-MB-
231 & MDA-MB-453) in this study where we cultured
these cell lines in the presence of mitochondrial complex I
inhibitor (rotenone) inhibitor for 25 generations thereby
creating metabolically adapted cell lines counterparts.
Metabolic analysis (in vitro and in vivo) of the parental
and modified cancer cells was carried out.
Results
Analysis of metabolic status in the isogenic parental and
metabolically modified adaptive breast cancer cells show
an overall improvement in mitochondrial function and
a reduction in metabolic switch phenotype. In vivo ana-
lysis of tumor xenografts revealed that metabolically
modified MDA231 cells displayed a ~50% reduction in
tumor growth/volume accompanied by a reduced in
vivo proliferation rate in comparison with the parental
MDA231 cells thereby confirming the physiological
relevance of metabolic adaptation in preclinical animal
models. In conclusion, long-term metabolic adaptation
to mitochondrial complex I modulators can be a unique
and novel strategy for achieving tumor control in vitro
and in vivo.
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